Depressed Female HIV Patients More Likely to Die

Article

WESTPORT, Conn-A new study shows women who are HIV-positive and have chronic depression symptoms are more likely to die than HIV-positive women without symptoms of depression.

Jeannette R. Ickovics, MD, from Yale University, used data from the HIV Epidemiologic Research Study to examine HIV-related mortality and CD4 cell counts among 765 HIV-seropositive women. The women were 16-55 years of age and were followed for seven years.

The women were classified as having limited or no depressive symptoms, intermediate depressive symptoms, or chronic symptoms. Those women who had symptoms of chronic depression were twice as likely to die as women with no symptoms of depression.

The women whose CD4 counts were less than 200 per microliter, the HIV-related mortality rate with chronic depression was 54% and for women with intermittent depressive symptoms the rate was 48%. These were compared to a rate of 21% for women with limited to no depressive symptoms.

Chronically depressed women also had a significantly greater decline in CD4 cell counts than other subjects.

The study concluded that further research is needed to treat depression and enhance mental health of women with HIV to stop disease progression.

For the latest information about HIV and AIDS see the following recent stories:

http://www.infectioncontroltoday.com/hotnews/13h2085937.html

http://www.infectioncontroltoday.com/hotnews/13h20161846.html

http://www.infectioncontroltoday.com/hotnews/13h16104932.html

Information from www.hivandhepatitis.com

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.